Talk:Warfarin

Skip to table of contents

This is the talk page for discussing improvements to the Warfarin article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1: 60 days

Warfarin has been listed as one of the Natural sciences good articles under the good article criteria. If you can improve it further, please do so. If it no longer meets these criteria, you can reassess it.

Article milestones
Date	Process	Result
January 21, 2009	Good article nominee	Listed

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Warfarin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine: Hematology-oncology Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force (assessed as High-importance).

Environment Mid‑importance

	Environment portal This environment-related article is part of the WikiProject Environment to improve Wikipedia's coverage of the environment. The aim is to write neutral and well-referenced articles on environment-related topics, as well as to ensure that environment articles are properly categorized. Read Wikipedia:Contributing FAQ and leave any messages at the project talk page.EnvironmentWikipedia:WikiProject EnvironmentTemplate:WikiProject EnvironmentEnvironment articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Coumadin +/- Marevan

Hi @Whywhenwhohow - just hoping to clarify your edit summary of "original name". Warfarin is primarily sold under the brand names Coumadin (no longer sold in the US and Canada, but still prescribed in Australia and some EU countries) and Marevan (see Australia's Acute Care NIMC etc), with Jantoven only being in the US if I am not misled. Is there a specific reason why you're concerned about including Marevan as the other primary brand name for warfarin (especially considering Marevan directs to Warfarin)? Tim (Talk) 05:40, 20 October 2024 (UTC)[reply]

The initial brand name is used. Other brand names can be added to the brand names section. See WP:MEDMOS. Whywhenwhohow (talk) 05:46, 20 October 2024 (UTC)[reply]

Ah, no worries. I'm just a bit confused though as WP:MEDMOS also says The alternative names may be specified in the lead - seems to have a bit of an internal contradiction. Considering that Coumadin seems to be progressively being discontinued, but that Marevan and Jantoven continue to be heavily prescribed, I guess I'm just wondering where the benefit/critical reasoning for only including an increasingly 'historic' name and not including significant, active brand names is? Tim (Talk) 05:51, 20 October 2024 (UTC)[reply]